Connect with us

  • AGS
    Liston

    50
    12

    Round 9

  • St Peters
    De La Salle

    32
    17

    Round 9

  • Aorere
    St Kents

    14
    50

    Round 9

  • Kelston
    KINGS

    14
    67

    Round 9

  • MAGS
    One Tree Hill

    40
    0

    Round 9

  • Dilworth
    Sacred Heart

    11
    54

    Round 9

  • HIBS
    Wellington

    0
    59

    Round 1

  • St Bernard's
    Aotea

    7
    43

    Round 1

  • SP Town
    Kapiti

    62
    18

    Round 1

  • Rongotai
    Scots

    19
    48

    Round 1

  • Wairarapa
    SP Silverstream

    12
    19

    Round 1

  • (9) NBHS
    WC

    34
    3

    Round 3

  • (13) Hastings
    (19) Scots

    22
    12

    Round 3

  • (14) PNBHS
    SP Town

    42
    8

    Round 3

  • Hamilton
    Tauranga

    39
    0

    Round 5

  • Westlake
    Whangarei

    28
    19

    Round 11

  • Massey
    Rosmini

    10
    28

    Round 11

  • Rangitoto
    Takapuna

    Round 11

  • Kings 2nd
    Taieri

    5
    41

    Round 9

  • Mt Aspiring
    Waitaki

    12
    21

    Round 9

  • Dunstan
    Kings

    3
    32

    Round 9

  • John McGlashan
    OBHS

    10
    25

    Round 9

  • Shirley
    Nelson

    3
    27

    Round 9

  • Andrews
    Lincoln

    15
    19

    Round 9

  • Marlborough
    CBHS

    17
    24

    Round 9

  • Waimea
    Christ's

    17
    49

  • St Thomas
    Rangiora

    36
    43

    Round 9

  • Aoraki
    St Bedes

    5
    98

    Round 9

  • Mid Canterbury
    Timaru Boys

    41
    41

    Round 9

  • Rathkeale
    (3) Feilding HS

    0
    27

    Round 8

Development of immuno-oncology drugs — from ctla4 to pd1 to the next generations, development of immuno-oncology drugs – from ctla4 to pd1 to the next generations

Base

Name

Development of immuno-oncology drugs — from ctla4 to pd1 to the next generations, development of immuno-oncology drugs – from ctla4 to pd1 to the next generations

Facebook

Recent Articles